Morbidity and Mortality of Heterotopic Partial Heart Transplantation in Rodent Models.
Savannah Skidmore, Morgan A Hill, Katherine Bishara...
https://pubmed.ncbi.nlm.nih.gov/37367399/Actively Recruiting
Led by Yonsei University · Updated on 2026-10-28
165
Participants Needed
3
Research Sites
13 weeks
Total Duration
Researchers are evaluating the efficacy and safety of injecting autologous adipose-derived mesenchymal stem cells ADMSCs into the knee joint compared to injections of hyaluronic acid HA in adults aged 40 to 70 with moderate knee osteoarthritis. This trial involves 165 participants with Kellgren-Lawrence grade II or III knee osteoarthritis who have persistent knee pain. The study is designed as a multicenter, randomized, active-controlled, and assessor-blinded trial to compare these treatments. Participants undergo abdominal fat harvesting to obtain their own stem cells, which are then culture-expanded. They are randomly assigned in a 21 ratio to receive either a single ultrasound-guided knee injection of ADMSCs 1.0 x 108 cells in 3 mL CryoStor 10 or a single injection of high molecular weight cross-linked hyaluronic acid 3 mL Synovian. Follow-up visits occur at 1, 3, and 6 months after injection. After the 6-month period, those initially receiving hyaluronic acid are offered the stem cell injection. During the study, participants will have their knee function and pain evaluated using the WOMAC total score as the primary outcome at 6 months. Additional assessments include pain scales VAS, knee injury outcome scores KOOS, imaging tests MRI and X-rays, use of rescue medications, and biomarker analysis. Safety is closely monitored throughout the 6-month follow-up. Total participation lasts 6 months post-injection with scheduled visits to track treatment effects and safety.
CONDITIONS
Autologous Adipose-Derived Stem Cell Injections for Knee Osteoarthritis
S
Sung-Hwan Kim, M.D., Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Yonsei University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants receive a single ultrasound-guided injection into the knee with either autologous adipose-derived mesenchymal stem cells or hyaluronic acid.
1 visit (injection day)
Duration - 6 months
Participants attend follow-up visits to assess knee pain, function, imaging, and safety at 1, 3, and 6 months post-injection.
3 visits (1, 3, and 6 months post-injection)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Savannah Skidmore, Morgan A Hill, Katherine Bishara...
https://pubmed.ncbi.nlm.nih.gov/37367399/Luis Servià, Mariona Jové, Joaquim Sol...
https://pubmed.ncbi.nlm.nih.gov/31118076/Elizabeth A Walshe, Daniel Romer, Abraham J Wyner...
https://pubmed.ncbi.nlm.nih.gov/35467733/Chris Hyunchul Jo, Young Gil Lee, Won Hyoung Shin...
https://pubmed.ncbi.nlm.nih.gov/24449146/Michael Ke Wang, Benjamin Chin-Yee, Carson Ka-Lok Lo...
https://pubmed.ncbi.nlm.nih.gov/30873722/Yonsei University
Lead Sponsor